Does DOSTARLIMAB Cause Pneumonitis? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Pneumonitis have been filed in association with DOSTARLIMAB (Jemperli). This represents 2.4% of all adverse event reports for DOSTARLIMAB.
21
Reports of Pneumonitis with DOSTARLIMAB
2.4%
of all DOSTARLIMAB reports
5
Deaths
17
Hospitalizations
How Dangerous Is Pneumonitis From DOSTARLIMAB?
Of the 21 reports, 5 (23.8%) resulted in death, 17 (81.0%) required hospitalization, and 2 (9.5%) were considered life-threatening.
Is Pneumonitis Listed in the Official Label?
Yes, Pneumonitis is listed as a known adverse reaction in the official FDA drug label for DOSTARLIMAB.
What Other Side Effects Does DOSTARLIMAB Cause?
Malignant neoplasm progression (111)
Thrombocytopenia (42)
Fatigue (38)
Anaemia (36)
Death (31)
Arthralgia (30)
Diarrhoea (29)
Rash (29)
Condition aggravated (27)
Dyspnoea (26)
What Other Drugs Cause Pneumonitis?
NIVOLUMAB (2,076)
PEMBROLIZUMAB (1,933)
METHOTREXATE (1,188)
PACLITAXEL (1,110)
CARBOPLATIN (975)
EVEROLIMUS (919)
IPILIMUMAB (891)
ATEZOLIZUMAB (842)
DURVALUMAB (827)
RITUXIMAB (747)
Which DOSTARLIMAB Alternatives Have Lower Pneumonitis Risk?
DOSTARLIMAB vs DOSTARLIMAB-GXLY
DOSTARLIMAB vs DOTATATE GALLIUM GA-68
DOSTARLIMAB vs DOTHIEPIN
DOSTARLIMAB vs DOXAZOSIN
DOSTARLIMAB vs DOXAZOSIN\DOXAZOSIN